Partner with an integrated life sciences company.
We work with biotechnology companies, research institutions, clinical sponsors and manufacturing partners.
One integrated platform, many ways to work together.
Because Syngenis spans discovery, manufacture and clinical delivery, we can meet a partner at any point on the pathway and travel the rest of the way together, with one accountable team and one chain of custody.
Partner across the pathway.
Whichever way you engage, you gain a partner that spans discovery, manufacturing and clinical capability on one platform, Discovery AI.
For biotechnology companies
Design candidates in Discovery AI, order validated material from our laboratories, and carry programs into regulated work with Syngenis Clinical, all in one place and one chain of custody, with intellectual property protected on home soil.
For research institutions and universities
Access custom oligonucleotides, design support and validated material on Australian soil, with documentation that supports grant and compliance needs, and R&D Tax Incentive claims.
For clinical sponsors
Run your nucleic acid trial with a specialist CRO that understands the modality from the sequence up, with onshore, sovereign material supply and one accountable partner from design to clinical study report.
For manufacturing partners
We are building global manufacturing partnerships to scale sovereign capability. Talk to us about supply and collaboration.
Trusted across the nucleic acid ecosystem.
We work alongside leading Australian and international universities, research institutes and biotechnology companies. Approved partner and client logos will be displayed here, with written permission confirmed for each.
Start a conversation
Tell us where you are on the pathway, and we will find the right way to work together, from candidate design to trial ready material.